Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
WaferGen Bio-systems, Inc. (WGBS)
|
Add to portfolio |
|
|
|
| Price: |
$6.90
| | Metrics |
| OS: |
18.9
|
M
| |
-568
|
% ROE
|
| Market cap: |
$131
|
M
| |
-4899
|
% ROIC
|
|
Net cash:
|
$2.15
|
M
| |
$0.11
|
per share
|
|
EV:
|
$128
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($14.9)
|
M
| |
|
|
|
EBIT
|
($15.9)
|
M
| |
|
|
| EPS |
($1.71)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 7.2 | 6.0 | 1.3 | 0.6 | 0.5 | 2.2 | 0.4 | 0.6 |
| Revenue growth | 19.4% | 359.9% | 122.6% | 12.1% | -75.9% | 471.3% | -39.0% | 171.6% |
| Cost of goods sold | 3.2 | 2.6 | 0.6 | 0.4 | 1.4 | 0.9 | 0.3 | 0.2 |
| Gross profit | 3.9 | 3.4 | 0.7 | 0.2 | -0.9 | 1.3 | 0.1 | 0.4 |
| Gross margin | 55.1% | 57.1% | 56.0% | 28.2% | -168.1% | 60.2% | 30.7% | 61.2% |
| Sales and marketing | 5.4 | 4.7 | 2.2 | 0.8 | 3.3 | 2.1 | 0.6 | 1.2 |
| Research and development | 9.3 | 6.7 | 5.4 | 6.2 | 8.3 | | 5.1 | 4.6 |
| General and administrative | 4.4 | 4.4 | 3.0 | 3.0 | 6.2 | 5.1 | 4.4 | 2.6 |
| EBITA | -14.6 | -12.0 | -6.5 | -10.4 | -9.4 | -12.6 | -10.0 | -8.0 |
| EBITA margin | -204.3% | -199.2% | -501.0% | -1772.4% | -1803.5% | -580.4% | -2638.6% | -1291.3% |
| Amortization of intangibles | 0.5 | 0.5 | | | | | | |
| EBIT | -15.1 | -12.5 | -6.5 | -10.4 | -9.4 | -12.6 | -10.0 | -8.0 |
| EBIT margin | -210.6% | -207.5% | -501.0% | -1772.4% | -1803.5% | -580.4% | -2638.6% | -1291.3% |
| Pre-tax income | -15.2 | -10.7 | -16.3 | -8.2 | -13.1 | -12.1 | -10.6 | -8.0 |
| Income taxes | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | 0.3% | | 0.0% | 0.0% | 0.0% |
| Net income | -20.0 | -10.7 | -17.7 | 0.0 | -22.8 | -12.8 | 0.0 | -8.1 |
| Net margin | -279.0% | -178.2% | -1357.5% | 0.0% | -4367.3% | -590.7% | -2.8% | -1299.2% |
| |
| Diluted EPS | ($2.58) | ($4.17) | ($58.16) | $0.00 | ($0.55) | ($0.35) | ($0.39) | ($0.33) |
| Shares outstanding (diluted) | 7.7 | 2.6 | 0.3 | 0.4 | 41.5 | 36.6 | 0.0 | 24.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|